MVT
- Nov 1, 2017
- 1 min read

Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using Same

Recent Posts

Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute

Microvascular Therapeutics enters licensing agreement with UNC Chapel Hill and Columbia University

Microvascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia University for the use of perfluorocarbon nanodroplets and ult

Microvascular Therapeutics receives NIH SBIR Phase I funds for its Alzheimer program

Tucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the Natio